SCHEMBL20150415

SCHEMBL20150415

Cc1ccc(-c2ccc3c4ccccc4n(-c4ccc(C#N)cc4-c4nc(C)nc(C)n4)c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.36
CHEK1 O14757 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
PPARG P37231 1/20 0.33
NCOA2 Q15596 1/20 0.33
NCOA1 Q15788 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
PDE10A Q9Y233 1/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
GRM2 Q14416 1/20 0.32
MAPKAPK2 P49137 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156218 0.96 PTGER4 (0.39) PTGER4CHEK1PDE10AMEN1KMT2A
SCHEMBL20150380 0.95 PTGER4 (0.37) PTGER4CHEK1NPSR1PDE10ALMNA
SCHEMBL20150391 0.95 CHEK1 (0.36) PTGER4CHEK1KDM4EHPGDPPARG
SCHEMBL20150390 0.94 PTGER4 (0.42) PTGER4L3MBTL1KDM4EHPGDPPARG
SCHEMBL20156150 0.93 PTGER4 (0.36) PTGER4CHEK1PDE10AMEN1KMT2A
SCHEMBL20114694 0.93 PTGER4 (0.38) PTGER4CHEK1KDM4EPDE10ALMNA
SCHEMBL20150384 0.92 PTGER4 (0.37) PTGER4KDM4EHPGDPDE10ALMNA
SCHEMBL20114689 0.92 PTGER4 (0.36) PTGER4CHEK1L3MBTL1KDM4EHPGD
SCHEMBL20114584 0.92 PTGER4 (0.36) PTGER4CHEK1PDE10ALMNAMEN1
SCHEMBL20156170 0.92 CYP1A2 (0.38) PTGER4KDM4ELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 PTGER4 1809/4885CHEK1 2795/4885L3MBTL1 2736/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 PTGER4 1809/4885CHEK1 2795/4885L3MBTL1 2736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.